Vanguard Global Advisers »

Gain Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $36k 18k 1.94

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Vanguard Capital Management
GSA Capital Partners
Jane Street
Vanguard Fiduciary Trust
BlackRock
UBS Group
Cresset Asset Management

View all funds holding Gain Therapeutics